Published • loading... • Updated
Conexeu Sciences Launches Human Collagen Initiative for Regenerative Aesthetics as GLP-1 Drives Demand for Tissue Restoration
Summary by The Hamilton Spectator
6 Articles
6 Articles
The Hamilton Spectator+4 Reposted by 4 other sources
Conexeu Sciences Launches Human Collagen Initiative for Regenerative Aesthetics as GLP-1 Drives Demand for Tissue Restoration
Highlights
·Hamilton, Canada
Read Full Article
Conexeu launches human collagen initiative for regenerative aesthetics - BioTuesdays
Conexeu Sciences (NASDAQ: CNXU) has launched a human collagen program at its Vancouver research and development facility for regenerative aesthetics, starting with the production of its first pilot batch of human type I collagen. According to Conexeu, demand for tissue restoration is rising with aging and with GLP-1 weight loss. The GLP-1 drug market was […]
Coverage Details
Total News Sources6
Leaning Left4Leaning Right1Center0Last UpdatedBias Distribution80% Left
Bias Distribution
- 80% of the sources lean Left
80% Left
L 80%
R 20%
Factuality
To view factuality data please Upgrade to Premium
